| DTMC |
NIDA-CTO-0011 |
Double-Blind, Placebo-Controlled, Dose Response Trial Of Ondansetron For The Treatment Of Methamphetamine Dependence |
Bankole Johnson, DSc., M.D., Ph.D. |
|
| DTMC |
NIDA-CTO-0012 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence |
Eugene Somoza, M.D. |
|
| DTMC |
NIDA-CTO-0008 |
Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence |
Richard Rawson, Ph.D. |
|
| DTMC |
NIDA-CSP-1022 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation |
Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH |
|
| DTMC |
NIDA-CSP-1021 |
Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence |
Liza Gorgon, M.A. |
|
| DTMC |
NIDA-CTO-0007 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence |
Steven Shoptaw, Ph.D., Thomas F. Newton, M.D. |
|
| DTMC |
NIDA-MDS-0007 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Bupropion For Methamphetamine Dependence |
Ann Anderson, M.D. |
|
| DTMC |
NIDA-MDS-0004 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For The Treatment Of Cocaine Dependence |
Domenic Ciraulo, M.D. |
|
| DTMC |
NIDA-CTO-0001 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence |
Eugene Somoza, M.D. |
|
| DTMC |
NIDA-CSP-1026 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For Methamphetamine Dependence |
Ahmed Elkashef, M.D. |
|
| DTMC |
NIDA-CSP-1025 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Topiramate For The Treatment Of Methamphetamine Dependence |
Bankole Johnson, DSc., M.D., Ph.D. |
|
